High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)

By sjmartinez • April 29, 2025

Riddler SA, Moodie Z, Clark J, Yen C, Allen M, Furch BD, Lu H, Grant S, Mondal K, Anderson M, Maenza J, Lemos MP, Woodward Davis AS, Walsh SR, Sobieszczyk ME, Frank I, Goepfert P, Stephenson KE, Baden LR, Tieu HV, Keefer MC, McElrath MJ, Kublin JG, Corey L. High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701. Epub ahead of print. PMID: 40294415.

Tags: Infectious Diseases, Publications

A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection

Fouladi F, Chen Y, Bera S, Jarmusch AK, Van Tyne D, Palella FJ, Margolick JB, Chew KW, Sun J, Martinson J, Rinaldo CR, Peddada SD.[...]

Use of Intrathecal Amphotericin for Coccidioidal Meningitis

Linfield RY, Gorenburg E, Liang JW, Rodriguez Nava G, El Kamari V, Parsonnet J. Use of Intrathecal Amphotericin for Coccidioidal Meningitis. Open Forum Infect Dis.[...]

First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo

Mukadi-Bamuleka D, Kinganda-Lusamaki E, Mulopo-Mukanya N, Amuri-Aziza A, O'Toole Á, Merritt S, Modadra-Madakpa B, Mutombo-Ndongala G, Vakaniaki EH, Kacita C, Maboko GL, Makangara-Cigolo JC, Ngimba[...]